期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 76, 期 -, 页码 2-20出版社
ELSEVIER
DOI: 10.1016/j.addr.2014.07.011
关键词
Angiogenesis; Positron emission tomography (PET); Single-photon emission computed tomography (SPECT); Cancer; Cardiovascular disease; Inflammation
资金
- University of Wisconsin - Madison [135-PRJ68QC, 1211-001]
- National Institutes of Health (NIBIB/NCI) [1R01CA169365, P30CA014520]
- Department of Defense [W81XWH-11-1-0644]
- American Cancer Society [125246-RSG-13-099-01-CCE]
Tremendous advances over the last several decades in positron emission tomography (PET) and single photon emission computed tomography (SPECT) allow for targeted imaging of molecular and cellular events in the living systems. Angiogenesis, a multistep process regulated by the network of different angiogenic factors, has attracted world-wide interests, due to its pivotal role in the formation and progression of different diseases including cancer, cardiovascular diseases (CVD), and inflammation. In this review article, we will summarize the recent progress in PET or SPECT imaging of a wide variety of vascular targets in three major angiogenesis-related diseases: cancer, cardiovascular diseases, and inflammation. Faster drug development and patient stratification for a specific therapy will become possible with the facilitation of PET or SPECT imaging and it will be critical for the maximum benefit of patients. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据